Some medical reports change a family’s life in a single afternoon.
This is one of those stories.
A 46-year-old woman. A known Hepatitis B patient. Already on antiviral medicines. Doing everything she was told. And then — a routine follow-up produced reports that nobody in the family was prepared for.
If you or someone in your family has Hepatitis B, a high AFP level, or has recently been diagnosed with liver cancer — this article is written for you.
1 Patient Background
Age: 46 years · Gender: Female · Medical history: Chronic Hepatitis B infection, on long-term antiviral therapy
This patient had been diagnosed with Hepatitis B several years before and was regularly taking antiviral medication. Her family believed the situation was under control. She had regular check-ups and her viral load was being monitored.
But over a period of weeks, new symptoms appeared:
- Persistent weakness and fatigue
- Loss of appetite
- Gradual but noticeable weight loss
- Mild discomfort in the upper abdomen
These symptoms are easy to dismiss. Fatigue can mean anything. Loss of appetite can follow stress or a stomach upset. But in a patient with chronic Hepatitis B, these symptoms need careful investigation — not reassurance.
Her doctors ordered a full investigation: blood tests including AFP (Alpha-fetoprotein), a contrast-enhanced CT scan of the abdomen, and a clinical review.
The findings were serious.
Multifocal Hepatocellular Carcinoma with Extrahepatic Spread
This was not an early-stage finding. The cancer had already progressed significantly within the liver and had spread beyond it.
2 What Is Hepatocellular Carcinoma (HCC)?
Hepatocellular Carcinoma — commonly called HCC — is the most common form of primary liver cancer. “Primary” means the cancer originated in the liver itself, rather than spreading to the liver from another organ.
HCC develops from hepatocytes — the main functional cells of the liver. It is one of the most common cancers globally and ranks among the leading causes of cancer-related deaths worldwide.
Key facts about HCC
- It most commonly develops in livers that are already damaged — from Hepatitis B, Hepatitis C, cirrhosis, or chronic alcohol use
- It can grow quietly for months before causing noticeable symptoms
- By the time symptoms appear, the disease is often at an intermediate or advanced stage
- Early-stage HCC can sometimes be treated with curative intent — surgery, ablation, or transplant
- Advanced HCC requires systemic treatment — immunotherapy, targeted therapy, or a combination
In this patient’s case, the HCC was multifocal — meaning multiple tumour nodules were present within the liver — and had spread beyond the liver to nearby lymph nodes and possibly the peritoneum (the lining of the abdominal cavity). This placed her in the advanced stage of the disease.
3 Can Hepatitis B Cause Liver Cancer?
This is the question many Hepatitis B patients and their families ask — and the honest answer is: yes, chronic Hepatitis B significantly increases the risk of developing liver cancer.
Here is how the progression typically happens:
When the liver is infected with Hepatitis B virus over many years, it experiences ongoing inflammation. This repeated injury causes the liver to form scar tissue — a process called fibrosis. Over time, severe fibrosis becomes cirrhosis, where large portions of the liver are replaced by scar tissue and can no longer function normally.
Cirrhotic livers have a significantly higher risk of developing HCC. But importantly — HCC can also develop in Hepatitis B patients who do not have cirrhosis. This is one of the features that makes Hepatitis B particularly dangerous compared to other liver conditions.
This does not mean every Hepatitis B patient will develop liver cancer. Many patients live long, healthy lives with proper antiviral treatment and monitoring. But it does mean that:
- Regular liver ultrasound every 6 months is essential
- AFP blood tests should be done as advised by the hepatologist
- Any new symptoms must be investigated promptly — not waited on
- Antiviral medicines must not be stopped without medical advice
In this case, the patient was doing everything right. She was on antiviral medication. She had follow-up appointments. But the cancer still developed — a reminder that Hepatitis B surveillance cannot be relaxed, even when viral load is controlled.
4 CT Scan Findings: What the Reports Showed
The contrast-enhanced CT scan of the abdomen revealed findings consistent with advanced HCC. Here is what the key terms in the report mean:
Multifocal HCC
Rather than a single tumour, multiple tumour nodules were visible within the liver. Multifocal disease generally indicates that the cancer has been growing for some time and is not limited to one area of the liver. Surgical removal of a single nodule is not possible in this setting.
Extrahepatic Spread
The term “extrahepatic” means “outside the liver.” In this case, the imaging showed involvement of nearby lymph nodes and raised concern about peritoneal deposits — small cancer deposits on the lining of the abdominal cavity. Extrahepatic spread confirms that the disease is in an advanced stage and that local treatments — surgery, ablation, or liver-directed therapy — are unlikely to be appropriate as the primary approach.
When HCC is multifocal and has spread beyond the liver, the treatment goal changes. The oncology team’s focus shifts from attempting to remove or destroy the tumour entirely to controlling the disease, slowing its progression, reducing symptoms, and maintaining the patient’s quality of life for as long as possible.
5 AFP Explained: What the Blood Test Revealed
In this patient, the AFP (Alpha-fetoprotein) level was reported at approximately 4,300.
What is AFP?
AFP is a protein produced by liver cells and some cancer cells. In healthy adults, AFP levels are very low — typically below 10 ng/mL. Significantly elevated AFP in a patient with liver disease and suspicious imaging is a strong indicator of HCC.
What does an AFP of 4,300 mean?
A level this far above normal, combined with the CT scan findings and the patient’s Hepatitis B history, supported the diagnosis of advanced HCC. The oncology team used AFP alongside imaging and clinical findings to form a complete picture — not AFP alone.
The limitation of AFP
AFP is not a perfect marker. Some HCC tumours do not produce elevated AFP. Some benign liver conditions can also raise AFP modestly. This is why AFP must always be interpreted alongside imaging and clinical context — never as a standalone test.
In monitoring terms, AFP can also be useful to track how a patient is responding to treatment. If treatment is working, AFP levels may fall over time.
6 Treatment Options Recommended
The oncology team presented two treatment options for this patient, based on her diagnosis of advanced HCC with extrahepatic spread.
Immunotherapy + Targeted Therapy (Atezolizumab + Bevacizumab)
This combination — commonly known by the brand names Tecentriq and Avastin — has become one of the standard first-line treatment options for advanced HCC based on clinical trial evidence.
How it works:
- Atezolizumab is an immunotherapy drug. It works by blocking a checkpoint protein (PD-L1) that cancer cells use to hide from the body’s immune system. By removing this block, the immune system can recognise and attack the cancer more effectively.
- Bevacizumab is an anti-angiogenic targeted therapy. It works by blocking VEGF — a protein that tumours use to grow new blood vessels. Without a new blood supply, the tumour’s ability to grow and spread is reduced.
Together, these two drugs attack the tumour from two directions — the immune system and the tumour’s blood supply.
How it is given: Both medicines are given intravenously (IV drip) every three weeks. The initial plan typically involves three cycles, after which a CT scan is done to assess the response. If the tumour is responding — shrinking or stable — treatment is usually continued.
Side effects to be aware of: Fatigue, decreased appetite, high blood pressure, risk of bleeding, skin reactions, and immune-related side effects. Not every patient experiences these, and the treating oncologist monitors closely throughout.
Lenvatinib (Oral Targeted Therapy)
Lenvatinib (brand name Lenvima) is an oral targeted therapy taken as a tablet daily. It works by blocking multiple proteins — including VEGF receptors and FGFR — that cancer cells use to grow and spread.
It is another first-line option for advanced HCC and may be preferred in patients where intravenous therapy is not suitable, or based on the oncologist’s clinical assessment of the individual patient.
Dose: Depends on body weight — typically 8mg or 12mg daily.
How the choice is made
The decision between Atezolizumab + Bevacizumab and Lenvatinib is not one-size-fits-all. The oncologist considers the patient’s liver function (Child-Pugh score), blood pressure, bleeding risk, overall fitness, co-existing conditions, Hepatitis B status, and personal preference. This is why an individualised consultation with an experienced hepato-oncologist is essential.
7 Liver Cancer Treatment Cost in India (2026)
One of the first questions this patient’s family asked was: “Doctor, how much will this cost?”
It is a completely valid question — and one that every family dealing with advanced cancer must plan for carefully.
| Treatment / Service | Approx. Cost (INR) | Approx. USD |
|---|---|---|
| Medical oncology consultation | ₹1,000 – ₹3,000 | $12 – $36 |
| Contrast CT scan (abdomen + chest) | ₹8,000 – ₹20,000 | $96 – $240 |
| AFP and liver function blood tests | ₹2,000 – ₹6,000 | $24 – $72 |
| Atezolizumab + Bevacizumab (one cycle) | ₹6,50,000 – ₹7,00,000 | $7,800 – $8,400 |
| Three cycles (initial treatment phase) | ₹18,00,000 – ₹21,00,000 | $21,600 – $25,200 |
| Lenvatinib (monthly) | ₹80,000 – ₹1,50,000 | $960 – $1,800 |
| Supportive medicines and anti-nausea | ₹5,000 – ₹20,000/month | $60 – $240 |
| Repeat CT scan (after 3 cycles) | ₹8,000 – ₹20,000 | $96 – $240 |
| Hepatitis B antiviral continuation | ₹1,500 – ₹8,000/month | $18 – $96 |
| Nutritionist and supportive care | ₹2,000 – ₹10,000/month | $24 – $120 |
Important notes on cost
- Medicine cost depends on body weight and dosage
- Hospital charges, room category, and administration fees vary significantly between hospitals
- Generic versions of some targeted therapy medicines may be available at lower cost — the oncologist can advise
- Some insurance plans and government schemes may cover part of the cost
- Financial counselling is available at many cancer centres in Bangalore
8 Can Advanced Liver Cancer Be Cured?
This was the most difficult question the family asked.
The oncologist’s answer was honest: the treatment intent for advanced HCC with extrahepatic spread is disease control — not cure.
This is important to understand, and it is not a reason to give up hope. Here is what disease control means in practice:
What treatment aims to achieve
- Slow the growth and spread of the cancer
- Reduce tumour size where possible
- Manage symptoms and maintain comfort
- Preserve liver function for as long as possible
- Improve or maintain quality of life
- Extend life expectancy
What the evidence shows
Clinical trials of Atezolizumab + Bevacizumab in advanced HCC have shown meaningful improvements in overall survival and progression-free survival compared to older treatments. Some patients respond very well and maintain stable disease for extended periods.
Individual variation matters
Some patients with advanced HCC live well beyond initial estimates. Response to immunotherapy can sometimes be remarkable. Some patients achieve significant tumour shrinkage. Others maintain stable disease for months or years. The trajectory is not fully predictable at the outset.
False hope vs. real hope
The oncologist’s role — and ours — is to neither promise a cure that cannot be promised, nor to take away the realistic hope that comes from modern medicine. Honest communication, individualised care, and strong support systems make an enormous difference to how patients and families navigate this journey.
9 Lessons from This Case
If this article reaches even one Hepatitis B patient who takes their next screening appointment more seriously, it has done its job.
Do Not Ignore Hepatitis B
Hepatitis B is a silent condition for most of the time. Taking antiviral medication reduces the viral load but does not eliminate the risk of liver cancer entirely. Treating Hepatitis B as a serious, lifelong condition — not a background issue — is essential.
Regular Liver Cancer Surveillance Saves Lives
The recommended surveillance for Hepatitis B patients is a liver ultrasound every six months, with AFP testing. This surveillance exists because HCC caught early — when it is small and confined to the liver — can sometimes be treated with curative intent. The same cancer caught late, as in this case, has far fewer options.
New Symptoms Must Be Investigated Promptly
Weakness, weight loss, loss of appetite, and abdominal discomfort are not specific symptoms. They can have many causes. But in a Hepatitis B patient, these symptoms should prompt early investigation — not watchful waiting.
Do Not Rely on the Internet for Treatment Decisions
Online forums, social media groups, and general health websites cannot replace a consultation with an experienced hepato-oncologist or medical oncologist. The treatment of HCC is complex, individualised, and rapidly evolving. What worked for one patient may not be appropriate for another.
Seek Multidisciplinary Care
The best cancer centres manage HCC through a Multi-Disciplinary Team (MDT) — oncologists, hepatologists, radiologists, interventional radiologists, surgeons, nutritionists, and palliative care specialists working together. This kind of integrated care produces the best outcomes.
10 When Should You Seek a Second Opinion?
A second opinion in cancer care is not a sign of distrust toward your current doctor. It is a recognised and respected part of good medical practice — especially in complex, advanced cancers like HCC.
Consider seeking a second opinion when:
- The diagnosis is serious or unexpected and you want confirmation
- Multiple treatment options have been offered and you are unsure which is right
- The treating hospital does not have a dedicated liver cancer MDT
- You are considering medical travel to India from another country
- The cost of recommended treatment is very high and you want to explore alternatives
- You feel uncertain about the treatment plan and need more clarity
A second opinion from a specialist liver cancer centre can sometimes reveal additional options — clinical trials, alternative drug combinations, liver-directed therapies, or transplant evaluation that may not have been initially considered.
11 How Doctor Visit Bangalore Can Help
At Doctor Visit Bangalore, we work with patients and families navigating serious diagnoses every day. We do not provide medical advice — but we help families find the right specialist, at the right hospital, with the right information, as quickly as possible.
We can help with:
Hospital selection — identifying the best cancer hospitals in Bangalore for liver cancer and HCC, based on your specific case.
Doctor appointments — coordinating consultations with experienced hepato-oncologists and medical oncologists.
Second opinion coordination — arranging review of reports and imaging at leading cancer centres.
International patient support — guidance for patients from Bangladesh, the Middle East, Africa, the UK, USA, and other countries.
Medical visa guidance — assistance with medical visa documentation and hospital invitation letters.
Treatment planning support — helping families understand options, cost estimates, and logistics before arriving in Bangalore.
Financial counselling coordination — connecting families with hospital financial counsellors to discuss payment plans, insurance, and cost options.
✓ Our service is free for patients — we are compensated by the hospitals and partners we work with. You never pay us anything for the guidance we provide.
12 Frequently Asked Questions
What is the survival rate for advanced HCC?
Is Atezolizumab + Bevacizumab available in India?
Can a Hepatitis B patient receive immunotherapy?
Can liver cancer patients from Bangladesh come to Bangalore for treatment?
What documents should I bring for a liver cancer consultation in Bangalore?
Is liver cancer treatable if detected early?
Final Word
This case is not shared to frighten anyone.
It is shared because the family of this 46-year-old patient asked us a question that thousands of families ask every year: “We did everything right. How did this happen? And what do we do now?”
The answer to the first question is complicated — Hepatitis B and liver cancer do not always follow a predictable path. The answer to the second question is clearer: find an experienced oncologist, get a full evaluation, understand your options honestly, plan financially, and do not face this alone.
Cancer does not always mean the end. But late diagnosis closes doors that early detection keeps open.
If you have Hepatitis B — please get your liver checked. If you have new symptoms — please get them investigated. If you have already received a serious diagnosis — please reach out. We are here to help you find the right path forward.
The right information, at the right time, changes everything.
Arman Ali is the founder of Doctor Visit Bangalore, a trusted healthcare navigation platform helping patients find verified doctors, hospitals, and specialists across Bangalore and all over in India. With hands-on experience in healthcare research and patient assistance, Arman has personally helped hundreds of domestic and international patients connect with leading hospitals including Apollo, Manipal, Fortis, and Aster. His content is grounded in real hospital data, treatment cost research, and direct coordination with medical professionals across Bangalore. He specializes in medical tourism guidance, treatment cost transparency, and specialist discovery for complex conditions including cancer, cardiac surgery, and orthopedic care.